NCT03793192

Brief Summary

This randomized controlled pilot study involving patients with chronic obstructive pulmonary disease (COPD) recently discharged from the hospital will evaluate the feasibility and efficacy of a home-based mobile-health supported physical activity promotion program.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 4, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

March 18, 2019

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 8, 2022

Completed
Last Updated

January 20, 2025

Status Verified

March 1, 2023

Enrollment Period

3.1 years

First QC Date

January 2, 2019

Last Update Submit

January 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in mean daily step counts

    change in mean daily step counts (averaged over 1 week) over time using repeated measures over the 12 weeks of the study.

    12 weeks

Secondary Outcomes (4)

  • Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress - Depression

    12 weeks

  • PROMIS Emotional Distress - Anxiety

    12 weeks

  • PROMIS Fatigue

    12 weeks

  • PROMIS Physical function

    12 weeks

Study Arms (2)

PACE2 Intervention

EXPERIMENTAL

All participants will receive usual healthcare as per their treating medical team and carry a pedometer for recording of physical activity. In addition, participants randomized to the PACE2 intervention will receive written educational materials regarding physical activity, telephone-based coaching to integrate physical activity in daily life activities and address barriers to attending pulmonary rehabilitation.

Other: PACE2 Intervention

Enhanced Usual Care

NO INTERVENTION

All participants will receive usual healthcare as per their treating medical team and carry a pedometer for recording of physical activity.

Interventions

Written educational materials regarding physical activity, telephone-based coaching to integrate physical activity in daily life activities and address barriers to attending pulmonary rehabilitation.

PACE2 Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older;
  • Physician diagnosis of COPD;
  • Hospitalized as an inpatient, 23-hour observation, or clinical decision unit
  • Admitting respiratory conditions sensitive to the Centers for Medicare and Medicaid Services Hospital Readmission Reduction Program as listed below:
  • COPD exacerbation
  • Asthma/COPD overlap
  • Decompensated heart failure
  • Pneumonia
  • Chronic Airway Disease

You may not qualify if:

  • Physical inability to participate in a walking program;
  • Oxygen saturation \<90% by pulse oximetry refractory to supplemental oxygen, or in a patient unable or unwilling to use supplemental oxygen;
  • Fall in the previous 6 months;
  • Resting electrocardiogram (ECG) with new ST changes or tachyarrhythmia;
  • Planned discharge home to hospice or to long term care facility/skilled nursing facility;
  • Life expectancy \<3 months;
  • Medical contraindication to participating in a physical activity promotion program as determined by the inpatient treating clinician;
  • Unable to communicate in English;
  • Unable or declines to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Illinois at Chicago

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jerry Krishnan, MD

    University of Illinois at Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Allocation sequence will be concealed
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Intervention versus Enhanced Usual Care
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 2, 2019

First Posted

January 4, 2019

Study Start

March 18, 2019

Primary Completion

April 8, 2022

Study Completion

April 8, 2022

Last Updated

January 20, 2025

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations